Viyash Scientific Limited.
Healthcare · Pharmaceuticals
Viyash Scientific Limited operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally. The company provides active pharmaceutical ingredients, finished dosage formulations, analytical services, and VET formulation services for cattle and poultry. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.
- Market cap
- ₹11,109 cr
- P/E (TTM)
- 65.6
- P/B (latest)
- 3.8
- ROE (TTM)
- 6.1%
- ROCE (TTM)
- 12.9%
- Sales CAGR 3y
- 34%
- PAT CAGR 3y
- 0%
- Debt / equity
- 0.15x
- Promoter
- 61.3%
- Dividend yield
- —
- Size
- Micro
- Codes
- VIYASH · 512529
₹238.05 · 29 Sept 2026
52-week ₹179.89 – ₹294.15 · ADTV ₹118.9 cr · price-only.
Sales and net profit by fiscal year, ₹ crore
Not in the Buoyant book: no house thesis or target is carried. Exchange masters, Tijori and the reference price feed as stated on each tab. All listed companies · NSE EQ